Purpose: Behavioral side effects of antiepileptic drugs (AEDs) are common including both positive and negative effects on mood, anxiety, depression, and psychosis. We aimed to evaluate behavioral patterns in rats after administration of lamotrigine, levetiracetam, phenytoin, topiramate, carbamazepine, gabapentin, pregabalin, and zonisamide.
Introduction
The effects of antiepileptic drugs (AED) on mood and behavior have not been fully understood so far. It is difficult to distinguish which psychopathological manifestations are induced by drug therapy, or perhaps are due to other factors affecting the patient. Psychiatric disorders in epilepsy are frequent and in many cases of multifactorial origin; AEDs constitute only one of the possible causes [1] . It has been suggested that seizures and psychiatric disorders may share an underlying brain abnormality, or may be causally related. Furthermore, the reason of comorbid psychiatric disorders observed in many patients with epilepsy may be iatrogenic [2] . In fact, both positive and negative behavioral effects have been associated with various AEDs [3] .
The open-field test (OFT) provides a popular animal model of anxiety-like behavior and permits the evaluation of drug related effects on different aspects of animal behavior. The first exposure to the OFT can be used to assess the effects of various drugs on the levels of anxiety as well as on non-specific effects of drugs on the locomotor activity. Upon repeated exposure to the OFT, animals quickly habituate to the OF and their locomotion tend to decrease [4] . The number of line crosses and the frequency of rearing are usually used as measures of locomotor activity, but these are also measures of exploration and anxiety. The high frequency of such behaviors indicates increased locomotion and exploration, and refers to a lower level of anxiety. Generally, rearing behavior is taken as an index of rodent emotionality (increased frequency of rears being associated with exploratory behavior). The number of central square entries and the duration of time spent in the central square, as well as latency to enter the central square are regarded as indicating measures of exploratory behavior and anxiety. Rodents spontaneously prefer staying in peripheries to activities in the center. Increased time spent in the central part or decreased latency to enter the central part are indications of anxiolysis [5] . Grooming behavior is a displacement response and is expected to be displayed in any novel environment. Grooming can serve to allay anxiety in stress situation. The role of grooming as a behavioral marker of depression has been much less studied, compared to the data on grooming responses to anxiety [6] . Defecation (number of fecal boli) is used as a measure of anxiety as well [7, 8] .
We aimed to describe behavioral patterns in rats after lamotrigine (LTG), levetiracetam (LEV), phenytoin (PHT), topiramate (TPM), carbamazepine (CBZ), gabapentin (GBP), pregabalin (PGB), zonisamide (ZNS) administration and to compare the behavioral effects of AEDs associated with depressive symptoms (TPM and ZNS) to AEDs with neutral or positive effects on mood, anxiety and depression (LTG, LEV, PHT, CBZ, GBP, PGB).
Methods

Animals
All animals received humane care in accordance with the guidelines set by the institutional Animal Use and Care Committee of Charles University, Prague, Faculty of Medicine in Hradec Kralove, Czech Republic. The protocol of the experiment was approved by the same committee. The experiments used eighty 24-week-old male albino Wistar rats (Biotest s.r.o., Konarovice, Czech Republic) and ended at the age of 36 weeks. The animals were hosted in groups of 4 in plastic cages (size: 60 Â 38 Â 20). During the experimental period the animals were maintained at controlled conventional conditions (12 h light and 12 h dark, temperature 22 AE 2C, air humidity 30-70%). Tap water and standard laboratory diet (SLD; VELAS, a.s., Lysa nad Labem, Czech Republic) or SLD enriched with AED were given ad libitum (besides the test period). The weight of rats was monitored once a week.
Rats weighing 256.3 g AE 17.7 SD (median: 258.5 g; SEM: 1.98) at the beginning of the experiment were divided into nine groups and received either SLD (16 controls) The open-field test was performed at the age of 36 weeks. At the end of the experiment, the 36-weeks old animals were sacrificed via blood withdrawal from the abdominal aorta under ether anaesthesia, and the serum obtained from the samples was aliquoted and stored at À80C for subsequent biochemical analyses. LTG, LEV, GBP, PGB, ZNS concentrations in the samples were determined using a modified high-performance liquid chromatography method with ultraviolet [9, 10] or mass spectrometry (MS) detection [11, 12] . Topiramate concentrations were determined using modified gas chromatography with MS detection [13] . Cobas Integra 400 Plus (based on Fluorescence Polarization Immunoassay) was used to measure PHT and CBZ concentrations using commercial kits provided by Roche.
Open-field test
The open field apparatus was constructed of wooden box and measured 60 Â 60 cm with 60 cm walls. The entire apparatus was painted black except for the floor in white. The lines divided the floor into sixteen evenly spaced squares (15 Â 15 cm). The central part consisted of 4 squares in the center of the apparatus. In the novel test situation, each animal was placed in the bottom right corner of the test apparatus and videotaped for 5 min using a video camera located 100 cm away from the arena. During each interval between the phases of experiments the arena was cleaned with cotton soaked in 70% alcohol. All videotapes were analyzed by experimenter. For each rat the following behaviors were recorded:
1. Locomotion: The number of lines crossed by the rat over 5-min interval 2. Rearing: The frequency of rats standing on their hind limbs 3. Self-grooming: rapid cleaning movements of the forelegs towards the face and/or the body. Both complete and noncomplete grooming interrupted at some point along the body were counted together. (A typical complete grooming bout starts with the rat scratching its face, progressively moving down along the body and terminating with the tip of the tail.) 4. Fecal pellets: The number of fecal pellets excreted by each individual rat 5. Central latency À the time delay to enter the central part of the apparatus (i.e. the four squares in the center of the apparatus). An entry into the central part was scored when the rat placed two front paws and the head in the respective area. Failure to enter the central part resulted in a latency score of 5 min for each measure.
Locomotor activity in the first and the fifth minute of observation was compared to determine if reactions to the environment decreased.
Statistical analysis
Statistical analysis was performed using R software version 3.2 (R Development Core Team, R Foundation for Statistical Computing, Vienna, Austria), with "nortest" package. Kruskal-Wallis nonparametric test assessed differences among the groups in case data were found to have non-normal distribution in Anderson-Darling test, and ANOVA for normally distributed data. To compare variables with a significant inter-group variability the Wilcoxon rank-sum test or t-test were used for data with nonnormal or normal distribution, respectively. The returned p-values were adjusted using the false discovery rate for multiple comparisons. The results were presented as median and the 25th and 75th percentiles. The level of statistical significance was preset to p < 0.05.
In the subsequent analysis we divided rats into three groups according to their exposure to AEDs [1,14, 
Results
Body weight and serum levels of AEDs are shown in Table 1 . The median body weight at the beginning of the experiment (24 weeks of age) and at the completion of treatment (36 weeks of age) were significantly different (p < 0.001, resp. p < 0.01) among the groups. Body weight in lamotrigine group was significantly lower (at week 36) when compared to body weight in the gabapentin, levetiracetam, pregabalin, topiramate or control group. Body weight gain was significantly reduced in lamotrigine, phenytoin, zonisamide and carbamazepine group in comparison with the control group (p < 0.001).
Open-field test
As shown in Table 2 , the experimental groups did not differ in latency to enter the center compartment, neither in the decline of locomotor activity in the 1st and the 5th minute of the observation, nor in number of rears. Significant differences among groups were seen in the total number of lines crossed, also in grooming and in the number of fecal pellets. Locomotor activity (number of crossing lines on the floor) significantly increased in lamotrigine compared with gabapentin and pregabalin (ANOVA; p < 0.05). Rats exposed to topiramate displayed significantly increased number of grooming (when compared to pregabalin; p < 0.01). Defecation (the number of fecal pellets) was significantly increased in the gabapentin and carbamazepine group compared with lamotrigine, phenytoin, levetiracetam and topiramate where the same number was lower (p < 0.001).
When we analyzed rat behavior in subgroups based on their potential effects on anxiety and depression, the frequency of grooming was significantly higher in the topiramate/zonisamide group compared to the group with neutral or positive effects on mood, anxiety or depression (p < 0.05). (Table 3) 4. Discussion
The aim of this study was to investigate the behavioral effects of antiepileptic drugs in the open field test. To examine the effects of AEDs we used the OFT as a well-established paradigm to measure locomotion, depression-like states, and anxiety-like behavior in animals. The open field test has been described as suitable model of measuring normal anxiety animals are faced by when confronted with a stressful or threatening situation, but not a model of pathological anxiety. The OFT seems to be sensitive to the anxiolytic effects produced by classical benzodiazepines and 5-HT 1A receptor agonists still not adequately sensitive to compounds effective in anxiety disorders [5] .
Lamotrigine increased the locomotor activity and exploration in our experiment with reduction in defecation seen in lamotrigine treated rats. Lamotrigine is known for its beneficial effects in reducing behavioral disturbance and in treating psychiatric disorders [16, 17] . It has been suggested that this positive effect on behavior may occur through the reduction of abnormal glutaminergic activity [18] . Higher locomotion and reduced defecation could confirm some anxiolytic effects of lamotrigine and the positive effects on mood seen in clinical practice.
Most of the reports of gabapentin have indicated that this drug may be of value in treating behavioral disturbances, rather than being its causative factor. There are many reports of the use of gabapentin as a mood stabilizer or as a treatment of anxiety, affective disorders, or panic disorders and is characterized as a drug with a "sedating" effect [3, 19] . Furthermore, improvement of movement disorders induced by antipsychotic medication has also been reported [20] . Locomotor activity was significantly reduced in rats receiving gabapentin in our study, while defecation was higher. Higher defecation rate is caused by activation of autonomic nervous system after exposition of the animal to stressful stimuli provided by novel environment [21] . However, the validity of defecation as appropriate measure on emotionality has been frequently questioned [22, 23] . Our results support the evidence that gabapentin may influence mood and movement disorders and exerts a sedating effect.
Pregabalin has been shown in many studies as a drug with anxiolytic effects [15] . Pregabalin decreased locomotion and grooming in our study, effects seen more in animals with higher level of anxiety. Our results correspond to some sedating effect of pregabalin [24] . It should be noted, that several types of grooming reactions are known and occur in various contexts. Grooming may reflect a stay of comfort or pleasure. However, this behavior or more frequently separate fragments of grooming are observed in situations of conflict as well. [25] . Since rodents' self-grooming is Data are expressed as median and 25th À 75th percentiles. Statistically significant differences: * p < 0.01; ** p < 0.001. Body weight at 24 weeks was significantly higher in carbamazepine, gabapentin, pregabalin and zonisamide groups compared to other AED groups (p < 0.001). At the age of 36 weeks the body weight in lamotrigine group was significantly lower (p < 0.01) when compared to body weight in the gabapentin, levetiracetam, pregabalin, topiramate or control group. Body weight gain was significantly reduced in lamotrigine, phenytoin, zonisamide and carbamazepine group in comparison with the control group (p < 0.001).
increased by both stress and comfort conditions, the traditional 'quantitative' measures of grooming may prove insufficient for correct data interpretation and analysis [26] . Increase in non-locomotor activity such as grooming was observed here in topiramate treated rats. Interestingly, increase in grooming was not accompanied by decrease in locomotion. Latency to enter the central part was slightly reduced but without statistical significance. Alaverdashvili et al. described prolonged time to leave the center by topiramate, indicating reduced anxiety and higher locomotion in the first post-injection session. The changes were time-dependent with increased signs of anxiety 24 h after TPM administration compared to 2 h after TPM administration. In accordance with our study, topiramate did not compromise habituation (the decrease in locomotor activity over time interval was similar in TPM-treated and control group) [27] . These results correspond to the studies indicating some anxiolytic effect of TPM. The mechanism of this effect could be explained by GABA-related action of topiramate, potentiation of GABAergic transmission and inhibition of excitatory pathways through an action at AMPA receptor sites [28] . Its mode of action is multifactorial and behavioral effects seen in clinical practice are both negative and positive (depression and psychosis versus improvement in mood disorders) [3] . In the study by Barker-Haliski et al. TPM was without effect on open field behavior. Vertical rearing activity, horizontal activity as well as total distance traveled were not reduced by TPM in this study [29] .
The latency to reach the center of the open field was not affected by any of the administered drugs. Since rats, especially during the first exposure, tend to stay in close contact with the walls in the open-field avoiding to enter open areas. Shorter latency to enter central part would have reflected decreased anxiety. Similarly, Choleris et al. showed that latency data (latency to enter center part, to leave the corner, to enter the inner ring etc.) provided little evidence of any effects of diazepam or chlordiazepoxide in OFT with mice [4] . This may indicate low predictive validity of this parameter in the behavioral effects of some drugs.
Behavioral changes have been reported after administration of anticonvulsive drugs that elevate brain g-aminobutyric acid (GABA) levels. Tiagabine has been shown to reduce aversion to open, bright areas and enhance exploration at higher doses (effects similar to those found for benzodiazepines). Anxiolytic effects of tiagabine were described in other studies [30] . Vigabatrin has been found to increase the exploratory behavior of rats in the elevated plus-maze model of anxiety, and to diminish general locomotor activity in the open-field test [31, 32] . Pregabalin is a structural analogue of GABA that nonetheless does not interact with GABA(A) or (B) receptors, does not get converted to GABA or a GABA agonist, and does not alter GABA uptake or degradation. Instead, it is Table 2 Open field behavior in rats exposed to AEDs (n = 8 rats in each AED group, 16 rats in control group). Rearing À total rearing with or without support; Grooming counted as total complete and non-complete grooming.
Table 3
Comparing rat behavior in the group receiving topiramate or zonisamide (Group 1) to the group receiving AEDs with neutral or positive effect on mood and depression (Group 2) and to the control group AED group Latency to enter the center part Group 2 included rats receiving lamotrigine, levetiracetam, phenytoin, carbamazepine, gabapentine, and pregabalin. Data expressed as median and 25th À 75th percentiles. *The frequency of grooming was significantly higher in the topiramate/zonisamide group compared to the group with neutral or positive effects on mood or depression (p < 0.05).
thought to exert its anxiolytic and other therapeutic effects by binding selectively and with high affinity to a2d auxillary subunits of P/Q-type voltage-dependant calcium channels (VDCCs) in hyper-excited neurons [33] . Gabapentin was developed to create a GABA neurotransmitter analogue. However, it exerts no GABA agonist effects and does not inhibit GABA uptake or degradation. The molecular mechanism of gabapentin can be explained by binding at the a2d1 subunit of Ca2+ channels affecting Ca2+ currents [34] . There have been several reports of the use of gabapentin as a mood stabilizer or as a treatment for affective disorders. However, adverse behavioral effects were recorded too, especially in children with intellectual disabilities [3] . In our study gabapentin and pregabaline were associated with decreased locomotion, whereas gabapentin increased defecation in rats. Topiramate, besides other mechanisms of action, enhances GABAevoked currents, the mechanism supporting some anxiolytic effects of topiramate and its site of action on GABAARs is independent of the BZ site [35] . However, most AEDs including topiramate have multiple mechanism of action leading to divergent mixture of behavioral effects. Phenytoin, carbamazepine, and zonisamide did not show any significant changes in locomotion or exploratory behavior. Modulation of voltage-dependent sodium channels as the primary mode of action of phenytoin and carbamazepine is unlikely to have a significant anxiolytic effect and psychiatric literature about these molecules is limited [15] . Carbamazepine is sometimes classified as a sedating drug or mood stabilizer, yet none of these effects were observed in our study [19] . Several studies reported higher prevalence of anxiety symptoms with zonisamide [36, 37] but due to mixed results from other studies the psychiatric effects of this drug are still not completely understood [14] .
We did not assess the effect of antiepileptic drugs on locationrelated behavior like staying in thigmotactic areas (corners and walls). In the study by Choleris et al. benzodiazepines did not affect total locomotion but did have differential effects on a variety of aspects of locomotion. Several effects of benzodiazepines were location dependent with the behaviors of exploration, walking, sitting and grooming being increased in the non-thigmotactic areas [4] .
The effect of AEDs might have been influenced by serum levels of AEDs. In carbamazepine, topiramate, and phenytoin the serum levels did not reach the therapeutic range (This therapeutic range refers to plasma levels valid for human patients and may not be of the same level in rats). Plasma levels of gabapentine and pregabaline were on the low limit of therapeutic range [38] . It might have been expected that the behavioral effects of these drugs would have been more pronounced at higher doses. Blood levels in lamotrigine and levetiracetam were quite high, reaching the upper limit of therapeutic range. Furthermore, it is really difficult to decide which AEDs have negative or positive effects on mood, anxiety or depression based on clinical evidence, and thus our division may seem questionable.
Little is known about AEDs effects on the open field behavior in rats. We can support the evidence that AEDs are able to influence several domains of behavior. However, the assessment and interpretation of these effects based on OFT are problematic. A better understanding of the behavioral effects of AEDs is of great importance, since people with epilepsy are often compromised by psychiatric comorbidities including anxiety disorders and depression. Appropriate anticonvulsive treatment with AED exerting positive influence on these comorbidities is crucial.
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